Building Systems to Address Tobacco Use in Oncology: Early Benefits and Opportunities From the Cancer Center Cessation Initiative

Restricted access

Disclosures: Dr. Beidas has disclosed that she is a consultant for Merck & Co., Inc. Schnoll has disclosed that he receives grant/research support from Pfizer, and is a consultant for Pfizer, GlaxoSmithKline, and Curaleaf. The remaining authors have no conflicts to disclose.Funding: This project was supported by a grant from the NCI (P30 CA016520-41S4) and from the National Institute on Drug Abuse (K24 DA045244). Dr. Jenssen is supported, in part, by the NCI (K08CA226390).Disclaimer: The views expressed here are those of the authors only and do not represent any official position of the NCI or NIH.
  • 1.

    Warren GW, Alberg AJ, Kraft AS, . The 2014 Surgeon General’s report: “the health consequences of smoking—50 years of progress”: a paradigm shift in cancer care. Cancer 2014;120:1914–1916.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Land SR, Toll BA, Moinpour CM, . Research priorities, measures, and recommendations for assessment of tobacco use in clinical cancer eesearch. Clin Cancer Res 2016;22:1907–1913.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Shields PG, Herbst RS, Arenberg D, . NCCN Clinical Practice Guidelines in Oncology for Smoking Cessation, Version 1.2016. J Natl Compr Canc Netw 2016;14:1430–1468. To view the most recent version, visit NCCN.org.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Nekhlyudov L, Lacchetti C, Davis NB, . Head and neck cancer survivorship care guideline: American Society of Clinical Oncology clinical practice guideline endorsement of the American Cancer Society guideline. J Clin Oncol 2017;35:1606–1621.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Toll BA, Brandon TH, Gritz ER, . AACR Subcommittee on Tobacco and Cancer. Assessing tobacco use by cancer patients and facilitating cessation: an American Association for Cancer Research policy statement. Clin Cancer Res 2013;19:1941–1948.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Goldstein AO, Ripley-Moffitt CE, Pathman DE, . Tobacco use treatment at the U.S. National Cancer Institute’s designated cancer centers. Nicotine Tob Res 2013;15:52–58.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Croyle RT, Morgan GD, Fiore MC. Addressing a core gap in cancer care - the NCI Moonshot Program to help oncology patients stop smoking. N Engl J Med 2019;380:512–515.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Vidrine JI, Shete S, Cao Y, . Ask-Advise-Connect: a new approach to smoking treatment delivery in health care settings. JAMA Intern Med 2013;173:458–464.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    Leone FT, Evers-Casey S, Mulholland MA, . Integrating tobacco use treatment into practice: billing and documentation. Chest 2016;149:568–575.

  • 10.

    Damschroder LJ, Aron DC, Keith RE, . Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci 2009;4:50.

    • Crossref
    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 913 913 69
PDF Downloads 139 139 7
EPUB Downloads 0 0 0